Latest News

CIMT

Riikka CIMT

Head of R&D Riikka Havunen was awarded oral presentation “Oncolytic adenoviruses armed with tumor necrosis factor alpha and interleukin-2 enable treatment of solid tumors with T cell therapies” at the 16th Cancer Immunotherapy Annual Meeting in Mainz, Germany in May 2018.

Poster of the presentation was also presented in the meeting.

Latest News

Upcoming Events

Please contact our business development team to meet us at the following events:

June 13-16th 2022
San Diego (CA), U.S.A.
28-29th September 2022
Malmö, Sweden
28th September - 1st of October 2022
New York City (NY), U.S.A.
24-26th October 2022
Leipzig, Germany